Understanding how food intake affects sleep in narcolepsy and hypersomnia patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the complex relationships between food intake, sleepiness, and nighttime sleep quality in patients with Type 1 Narcolepsy and Idiopathic Hypersomnia. It aims to explore how dietary habits and sleep patterns influence obesity and overall health in these populations compared to healthy controls. Participants will be monitored for their eating behaviors, sleep/wake rhythms, and sleep parameters to gather comprehensive data on these interactions. The findings could lead to better management strategies for obesity in narcolepsy patients and insights into the effects of diet on sleep quality.

Why it matters

Who can join: the full rules

Inclusion Criteria :

* Patients with NT1 or IH (ICSD-3-TR) or Healthy Controls without sleep disorder
* Familiar use of a smartphone

Exclusion Criteria :

* Untreated moderate or severe sleep apnea syndrome;
* Cognitive disorders incompatible with the protocol;
* Unstable treatment or treatment with sodium oxybate;
* Unstable medical or psychiatric pathology;
* Shift work;
* Pregnancy or breastfeeding;
* Diabetes

Where it's running

• Center for Sleep Medicine, Hospices Civils de Lyon
  Lyon, France Recruiting
• Unité de Neurophysiologie-sommeil, Département de Neurologie, CHU de Clermont-Ferrand
  Clermont-Ferrand, France Not yet recruiting

Study contacts

• Principal investigator: Laure PETER-DEREX, MD-PhD — Hospices Civils de Lyon
• Study coordinator: Laure PETER-DEREX, MD-PhD
• Email: Laure.peter-derex@chu-lyon.fr
• Phone: +33 472071929

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term test of TAK-360 in people with narcolepsy or idiopathic hypersomnia

  This study tests TAK-360 over an extended period to see if it is tolerable for people with narcolepsy type 1, narcolepsy type 2, or idiopathic hypersomnia who completed an earlier TAK-360 trial.

  Recruiting at 33 sites Phase 2/3 Takeda · Chula Vista, California and 32 other locations · NCT07646678

• Long-term ORX750 treatment for people with narcolepsy or idiopathic hypersomnia

  This open-label extension will try continued ORX750 treatment in people with narcolepsy or idiopathic hypersomnia who completed the earlier ORX750 parent study.

  Recruiting at 24 sites Phase 2 Centessa Pharmaceuticals (UK) Limited · Auburn, Alabama and 23 other locations · NCT07096674

• Long-term treatment with ALKS 2680 for narcolepsy and idiopathic hypersomnia

  This study is testing how well a new medication called ALKS 2680 works for people with narcolepsy or idiopathic hypersomnia over a long period of time.

  Recruiting at 50 sites Phase 2/3 Alkermes, Inc. · Cullman, Alabama and 49 other locations · NCT06767683

• Testing ORX750 for Narcolepsy and Idiopathic Hypersomnia

  This study is testing a new medication called ORX750 to see if it can help people with narcolepsy or idiopathic hypersomnia feel more awake and improve their daily lives.

  Recruiting at 37 sites Phase 2 Centessa Pharmaceuticals plc · Auburn, Alabama and 36 other locations · NCT06752668

• Exploring mind-wandering and its effects in narcolepsy and hypersomnolence

  This study is testing how daydreaming affects thinking and creativity in people with narcolepsy and excessive sleepiness.

  Recruiting Hospices Civils de Lyon · Lyon · NCT06457945

• Temporal interference stimulation for narcolepsy type 1

  A noninvasive brain stimulation test to see if theta-burst temporal interference can help people with narcolepsy type 1.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07727239

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.